Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Each stock option has an exercise price per share equal to $43.01 per share, Mirum's closing trading price on March 10, 2025, and will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the applicable vesting commencement date and the balance of the underlying shares vesting monthly thereafter over 36 months, subject to the new employees' continued service relationship with Mirum through the applicable vesting dates. The RSUs will vest over three years, with 33% of the underlying shares vesting on each anniversary of the applicable vesting commencement date, subject to the new employees' continued service relationship with Mirum through the applicable vesting dates. The awards are subject to the terms and conditions of Mirum's 2020 Inducement Plan and the terms and conditions of an applicable award agreement covering the grant.
About Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat) oral solution, CHOLBAM® (cholic acid) capsules, and CTEXLI™ (chenodiol) tablets.
LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients 12 months of age and older; in Europe, it is approved for patients with PFIC three months of age and older. Mirum is also initiating the Phase 3 EXPAND study, a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms of liver disease. CTEXLI is FDA-approved for the treatment of cerebrotendinous xanthomatosis (CTX) in adults.
Mirum's late-stage pipeline includes two investigational treatments for several rare diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2 VISTAS study for primary sclerosing cholangitis (PSC) and Phase 2b VANTAGE study for primary biliary cholangitis. Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Mirum is also planning for a Phase 2 study evaluating MRM-3379, a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder.
To learn more about Mirum, visit mirumpharma.com and follow Mirum on Facebook, LinkedIn, Instagram and Twitter (X).
View source version on businesswire.com: https://www.businesswire.com/news/home/20250310169622/en/
Contacts
Investor Contact: Andrew McKibbenir@mirumpharma.com
Media Contact: Erin Murphymedia@mirumpharma.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Viavi Solutions Inc. (VIAV): A Bull Case Theory
We came across a bullish thesis on Viavi Solutions Inc. on Viavi Solutions Inc. In this article, we will summarize the bulls' thesis on VIAV. Viavi Solutions Inc.'s share was trading at $10.31 as of July 23rd. VIAV's trailing and forward P/E were 515.50 and 17.86, respectively according to Yahoo Finance. Image by Akela999 from Pixabay Viavi Solutions Inc. (NASDAQ: VIAVI) is a global leader in network test, monitoring, and assurance solutions that underpin the reliable deployment of AI applications across data centers and enterprise networks. The company's technology enables high-speed, high-integrity data infrastructure critical for AI workloads, supporting both hyperscale and enterprise data centers as AI transitions from the compute build-out to application deployment. Viavi's offerings ensure network performance from the core data centers, where compute is concentrated, to the edge, where AI inference increasingly takes place. Its advanced optical technologies serve a broad range of industries, reinforcing its role as an indispensable enabler in the AI ecosystem. With AI entering Phase 2, the acceleration of application deployment, the demand for reliable and efficient network infrastructure has become more urgent, as the return on heavy capital expenditure depends on seamlessly running these AI systems. Viavi is well-positioned to capitalize on this need, providing the critical assurance that network systems will function smoothly as AI-driven workloads scale. The company was recently added to the portfolio and subsequently increased during broader market weakness, reflecting strong conviction in its growth trajectory. Viavi stands to benefit meaningfully as the focus shifts from building AI compute capacity to unlocking value through the widespread deployment of AI applications, particularly at the network edge, where its solutions are mission-critical. This unique positioning creates a compelling investment case as Viavi's role becomes increasingly integral to the realization of AI's next growth phase. Previously, we covered a bullish thesis on Trex Company, Inc. (TREX) by Stock Analysis Compilation in June 2025, which highlighted structural growth in composite decking, Trex's market leadership, and strong secular tailwinds. The company's stock price has appreciated by approximately 18.18% since our coverage as the thesis played out. The thesis still stands as composite adoption rises. The Viavi Solutions Inc. author shares a contrarian view, emphasizing AI-driven network infrastructure growth. Viavi Solutions Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 30 hedge fund portfolios held VIAV at the end of the first quarter which was 28 in the previous quarter. While we acknowledge the potential of VIAV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
CHTR Misses on Q2 Earnings, Reports Modest Y/Y Revenue Growth
Charter Communications CHTR has reported second-quarter 2025 earnings of $9.18 per share, which missed the Zacks Consensus Estimate by 8.66%. However, the reported figure increased 8.1% year over of $13.8 billion increased 0.6% year over year, driven by growth in residential mobile service, residential Internet and other revenue streams. The top line beat the consensus mark by 0.08%.CHTR has shown a mixed earnings surprise, missing the Zacks Consensus Estimate in one of the trailing four quarters while exceeding it in the other three, with an average surprise of 5.05%. Charter Communications, Inc. Price, Consensus and EPS Surprise Charter Communications, Inc. price-consensus-eps-surprise-chart | Charter Communications, Inc. Quote CHTR's Segmental Details Residential revenues totaled $10.72 billion in the second quarter, which decreased 0.4% year over 2025 monthly residential revenues per residential customer totaled $122.86 and increased 1.7% year over revenues grew 2.8% year over year to $5.97 revenues totaled $3.48 billion in the second quarter, decreasing 9.9% year over year. Voice revenues decreased 0.8% year over year to $346 mobile service revenues totaled $921 million, up 24.9% year over revenues increased 0.8% year over year to $1.84 and large business revenues, excluding wholesale, increased 3.5% year over year. Second-quarter advertising sales were $371 million, which decreased 6.7% year over year, primarily driven by lower political political revenues in both periods, advertising sales revenues decreased 4.4% year over year due to a more challenging advertising revenues totaled $839 million in the second quarter, reflecting a rise of 18.9% from the second quarter of 2024, primarily driven by higher mobile device sales. CHTR's Subscriber Statistics Second-quarter total residential and SMB Internet customers decreased 2% year over year to 31.2 total Internet customers decreased by 117 thousand compared with a decline of 149 thousand in the year-ago period. As of June 30, 2025, Charter had 29.9 million total Internet video customers decreased 80 thousand in the second quarter of 2025 compared with a decline of 408 thousand in the year-ago quarter. As of June 30, 2025, Charter had 12.63 million total video the second quarter of 2025, total wireline voice customers decreased 220 thousand compared with a decline of 220 thousand in the year-ago quarter. As of June 30, 2025, Charter had 6.38 million total wireline voice added 500 thousand total mobile lines compared with 557 thousand in the year-ago quarter. As of June 30, 2025, the company served 10.89 million mobile lines. Operating Details Total operating costs and expenses increased 0.6% year over year to $8.07 programming costs decreased 8.8% year over year due to fewer video customers, a higher mix of lower-cost packages within Charter's video customer base and $67 million of costs, which accounting principles require to be allocated to programmer streaming applications and netted within video costs of revenues increased 7.3% year over year, driven by higher mobile device sales and mobile service direct and technology operations increased 4.3% year over year, and customer operations increased 3% year over year, partly offset by lower labor and residential sales expenses increased 8.6% year over year, given Spectrum's continued focus on driving growth. Other expenses decreased 0.6% year over EBITDA increased 0.5% year over year to $5.7 billion. Balance Sheet & Cash Flow As of June 30, 2025, the total principal amount of debt was $94.3 billion, and Charter's credit facilities provided approximately $5.8 billion of additional liquidity over its $606-million cash the second quarter of 2025, net cash flows from operating activities totaled $3.6 billion. Capital expenditure totaled $2.9 billion in the second quarter of 2025, an increase of $21 million from the year-ago quarter, driven by the timing of CPE and upgrade/rebuild, partly offset by line free cash flow in the second quarter of 2025 totaled $3.6 billion, reflecting a decrease of $3.9 billion from the first quarter of 2024. The year-over-year increase in the free cash flow was primarily driven by mobile device working capital the reported quarter, Charter purchased 4.5 million shares of Charter Class A common stock and Charter Holdings common units for $1.7 billion. Zacks Rank & Stocks to Consider CHTR currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the broader Zacks Consumer Discretionary sector are Accel Entertainment ACEL, Laureate Education LAUR and Revolve Group RVLV, each carrying a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today's Zacks #1 Rank stocks of Accel Entertainment have gained 16.3% year to date. Accel Entertainment is set to report second-quarter 2025 results on Aug. of Laureate Education have risen 27.6% year to date. Laureate Education is slated to report second-quarter 2025 results on July of Revolve Group have lost 34.7% year to date. Revolve Group is set to report second-quarter 2025 results on Aug. 5. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Charter Communications, Inc. (CHTR) : Free Stock Analysis Report Laureate Education (LAUR) : Free Stock Analysis Report Revolve Group, Inc. (RVLV) : Free Stock Analysis Report Accel Entertainment, Inc. (ACEL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Mohawk's Q2 Earnings & Revenues Beat Estimates, Stock Up
Mohawk Industries, Inc. MHK reported second-quarter 2025 results, with earnings and net sales beating the Zacks Consensus Estimate. On a year-over-year basis, the top line remained flat, while the bottom line of this leading global flooring manufacturer gained 1.1% in yesterday's after-hours trading quarterly results reflect the impact of Mohawk's ongoing efforts in operations, cost control and market development. Performance was supported by new premium residential and commercial product collections launched over the past two years. The company benefited from restructuring actions such as shutting high-cost sites, removing inefficient assets, and improving distribution and administration through continued to focus on reducing costs. The company worked on enhancing equipment use, saving energy, improving supply-chain processes and redesigning products. Pricing pressure from weaker market volumes remained, but the company aimed to offset this through a better product and channel rising tariffs, Mohawk highlighted the advantage of its manufacturing base in North America. The company took steps such as adjusting prices and optimizing supply chains. The U.S. government has set a new deadline for trade negotiations and the company is closely tracking developments to adjust its strategy. Inside MHK's Q2 Numbers Mohawk reported adjusted earnings per share (EPS) of $2.77, which beat the Zacks Consensus Estimate of $2.62 by 5.7%. In the year-ago quarter, the company reported an adjusted EPS of $3. Net sales of $2.8 billion beat the consensus estimate of $2.79 billion by 0.4% and remained essentially flat year over year. On an adjusted basis, net sales were down 0.8% year over year. Mohawk Industries, Inc. Price, Consensus and EPS Surprise Mohawk Industries, Inc. price-consensus-eps-surprise-chart | Mohawk Industries, Inc. Quote Adjusted gross margin contracted 70 basis points (bps) year over year to 26.4%. Adjusted selling, general and administrative expenses, as a percent of net sales, rose 60 bps to 18.5% from the year-ago period. Adjusted operating margin contracted 120 bps to 8% from 9.2% a year ago. Mohawk's Segmental Details Global Ceramic: Sales in the segment totaled $1.12 billion, up 0.5% year over year on a reported basis. On an adjusted basis, sales were up 1.1% from the year-ago level to $1.13 billion. Adjusted operating income decreased to $90.3 million from $94.8 million a year ago. The segment's adjusted operating margin contracted to 8.1% from 8.5% a year North America: Net sales of the segment amounted to $946.8 million, down 1.2% year over year on a reported basis. The segment registered an adjusted operating profit of $69.2 million, down from $82 million reported in the prior-year period. Adjusted operating margin was 7.3%, down from 8.6% a year Rest of the World: Net sales in the segment increased 1% year over year on a reported basis to $734.4 million. On an adjusted basis, sales were down 3% from the year-ago level to $705 million. Adjusted operating income was $76.4 million, down from $91.4 million reported a year ago. The segment's adjusted operating margin was 10.4%, down from 12.6% in the year-ago period. Financial Highlights of MHK As of June 28, 2025, it had cash and cash equivalents of $546.7 million compared with $497.4 million on June 29, 2024. The long-term debt, less the current portion, was $1.74 billion compared with $1.69 billion at the end of second-quarter the end of the second quarter, the company generated free cash flow of $126.1 million compared with $142.2 million a year ago. Focus on Operational Discipline Amid Market Uncertainty The company is focusing on market development, operational efficiency and cost control to navigate current industry challenges. Ongoing inflation and weak consumer confidence are affecting overall sales. The timing of a recovery remains support sales growth, the company is using its brand strength, product range and service to expand with existing and new customers. While pricing pressure stays high, the company is improving its mix with premium products, commercial sales and recent launches. Input cost pressure is expected to peak in the third quarter as higher costs pass through measures are being implemented across operations to offset rising costs. Restructuring efforts are expected to result in about $100 million in savings this year. Most U.S. sales come from North America's production, which may help the company under changing trade policies. MHK's Q3 View MHK expects adjusted EPS in the range of $2.56-$2.66, excluding restructuring and other charges, compared with the year-ago figure of $2.9. The guidance does not reflect potential new tariffs, which are yet to be finalized. MHK's Zacks Rank & Recent Consumer Discretionary Releases Mohawk currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks Worldwide Holdings Inc. HLT reported second-quarter 2025 results, wherein earnings and revenues surpassed the Zacks Consensus Estimate. The top and bottom lines increased on a year-over-year delivered strong bottom-line performance in the quarter, underscoring the strength and resilience of its business model. However, top-line results were modestly impacted by unfavorable holiday and calendar shifts, reduced government spending, softer international inbound travel and broader economic uncertainty. Hasbro, Inc. HAS reported second-quarter fiscal 2025 results, with earnings and revenues beating the Zacks Consensus Estimate. The top line declined year over year while the bottom line increased from the prior-year's quarter figure. The downside was mainly due to weaker contributions from the Consumer Products and Entertainment Hasbro raised its full-year revenue and adjusted EBITDA guidance. The update was supported by strong performance in the Wizards segment, along with steady contributions from the games portfolio, licensing partnerships and digital initiatives. Despite ongoing macroeconomic challenges, Hasbro expects cost efficiency measures and business diversification to support its growth plans for 2025 and Inc. MAT reported second-quarter 2025 results, with earnings beating the Zacks Consensus Estimate and revenues missing the same. The top line fell year over year, while the bottom line came in line with the prior-year quarter's delivered a resilient second-quarter performance, underscoring its focus on operational execution amid a challenging macroeconomic backdrop. The company achieved significant gross margin expansion, international growth and continued momentum in its entertainment slate. While global trade dynamics and shifts in retailer ordering patterns weighed on its U.S. business, adjusted EPS held steady year over year. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Hasbro, Inc. (HAS) : Free Stock Analysis Report Mattel, Inc. (MAT) : Free Stock Analysis Report Mohawk Industries, Inc. (MHK) : Free Stock Analysis Report Hilton Worldwide Holdings Inc. (HLT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
